{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:23:35Z","timestamp":1785835415099,"version":"3.56.0"},"reference-count":39,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T00:00:00Z","timestamp":1572048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["16806"],"award-info":[{"award-number":["16806"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["32158"],"award-info":[{"award-number":["32158"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN\u20102014\u201005643"],"award-info":[{"award-number":["RGPIN\u20102014\u201005643"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["physoc.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Experimental Physiology"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:sec><jats:title>New Findings<\/jats:title><jats:p><jats:list list-type=\"bullet\">\n<jats:list-item><jats:p><jats:bold>What is the central question of this study?<\/jats:bold><\/jats:p>\n<jats:p>Acetazolamide and methazolamide both reduce hypoxic pulmonary vasoconstriction equally, but methazolamide does not impair skeletal muscle function. The effect of methazolamide on respiratory control in humans is not yet known.<\/jats:p>\n<\/jats:list-item>\n<jats:list-item><jats:p><jats:bold>What is the main finding and its importance?<\/jats:bold><\/jats:p>\n<jats:p>Similar to acetazolamide after chronic oral administration, methazolamide causes a metabolic acidosis and shifts the ventilatory CO<jats:sub>2<\/jats:sub> response curve leftwards without reducing O<jats:sub>2<\/jats:sub> sensitivity. The change in ventilation over the change in log <jats:inline-graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"graphic\/eph12606-math-0001.png\" xlink:title=\"urn:x-wiley:09580670:media:eph12606:eph12606-math-0001\"\/> provides a more accurate measure of hypoxic sensitivity than the change in ventilation over the change in arterial oxyhaemoglobin saturation.<\/jats:p>\n<\/jats:list-item>\n<\/jats:list><\/jats:p><\/jats:sec><jats:sec><jats:title>Abstract<\/jats:title><jats:p>Acetazolamide is used to prevent\/treat acute mountain sickness and both central and obstructive sleep apnoea. Methazolamide, like acetazolamide, reduces hypoxic pulmonary vasoconstriction, but has fewer side\u2010effects, including less impairment of skeletal muscle function. Given that the effects of methazolamide on respiratory control in humans are unknown, we compared the effects of oral methazolamide and acetazolamide on ventilatory control and determined the ventilation\u2013log\u00a0<jats:inline-graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"graphic\/eph12606-math-0002.png\" xlink:title=\"urn:x-wiley:09580670:media:eph12606:eph12606-math-0002\"\/> relationship in humans. In a double\u2010blind, placebo\u2010controlled, randomized cross\u2010over design, we studied the effects of acetazolamide (250\u00a0mg three times daily), methazolamide (100\u00a0mg twice daily) and placebo in 14 young male subjects who were exposed to 7\u00a0min of normoxic hypercapnia and to three levels of eucapnia and hypercapnic hypoxia. With placebo, methazolamide and acetazolamide, the CO<jats:sub>2<\/jats:sub> sensitivities were 2.39\u00a0\u00b1\u00a01.29, 3.27\u00a0\u00b1\u00a01.82 and 2.62\u00a0\u00b1\u00a01.79 l\u00a0min<jats:sup>\u22121<\/jats:sup>\u00a0mmHg<jats:sup>\u22121<\/jats:sup> (n.s.) and estimated apnoeic thresholds 32\u00a0\u00b1\u00a03, 28\u00a0\u00b1\u00a03 and 26\u00a0\u00b1\u00a03\u00a0mmHg, respectively (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001, placebo <jats:italic>versus<\/jats:italic> methazolamide and acetazolamide). The relationship between ventilation (<jats:inline-graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"graphic\/eph12606-math-0003.png\" xlink:title=\"urn:x-wiley:09580670:media:eph12606:eph12606-math-0003\"\/>) and log\u00a0<jats:inline-graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"graphic\/eph12606-math-0004.png\" xlink:title=\"urn:x-wiley:09580670:media:eph12606:eph12606-math-0004\"\/> (using arterialized venous <jats:inline-graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"graphic\/eph12606-math-0005.png\" xlink:title=\"urn:x-wiley:09580670:media:eph12606:eph12606-math-0005\"\/> in hypoxia) was linear, and neither agent influenced the relationship between hypoxic sensitivity (<jats:inline-graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"graphic\/eph12606-math-0006.png\" xlink:title=\"urn:x-wiley:09580670:media:eph12606:eph12606-math-0006\"\/>) and arterial [H<jats:sup>+<\/jats:sup>]. Using <jats:inline-graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"graphic\/eph12606-math-0007.png\" xlink:title=\"urn:x-wiley:09580670:media:eph12606:eph12606-math-0007\"\/> rather than \u0394<jats:inline-graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"graphic\/eph12606-math-0008.png\" xlink:title=\"urn:x-wiley:09580670:media:eph12606:eph12606-math-0008\"\/>\/\u0394 arterial oxyhaemoglobin saturation enables a more accurate estimation of oxygenation and ventilatory control in metabolic acidosis\/alkalosis when right\u2010 or leftward shifts of the oxyhaemoglobin saturation curve occur. Given that acetazolamide and methazolamide have similar effects on ventilatory control, methazolamide might be preferred for indications requiring the use of a carbonic anhydrase inhibitor, avoiding some of the negative side\u2010effects of acetazolamide.<\/jats:p><\/jats:sec>","DOI":"10.1113\/ep088058","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T08:44:26Z","timestamp":1570610666000},"page":"293-301","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Influence of methazolamide on the human control of breathing: A comparison to acetazolamide"],"prefix":"10.1113","volume":"105","author":[{"given":"Luc J.","family":"Teppema","sequence":"first","affiliation":[{"name":"Department of Anesthesiology Leiden University Medical Center  Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0477-6511","authenticated-orcid":false,"given":"Lindsey M.","family":"Boulet","sequence":"additional","affiliation":[{"name":"Centre for Heart, Lung, and Vascular Health School of Health and Exercise Science University of British Columbia  Kelowna BC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather K.","family":"Hackett","sequence":"additional","affiliation":[{"name":"Centre for Heart, Lung, and Vascular Health School of Health and Exercise Science University of British Columbia  Kelowna BC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5575-4043","authenticated-orcid":false,"given":"Paolo B.","family":"Dominelli","sequence":"additional","affiliation":[{"name":"Centre for Heart, Lung, and Vascular Health School of Health and Exercise Science University of British Columbia  Kelowna BC Canada"},{"name":"Department of Kinesiology University of Waterloo  Waterloo ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Cheyne","sequence":"additional","affiliation":[{"name":"Centre for Heart, Lung, and Vascular Health School of Health and Exercise Science University of British Columbia  Kelowna BC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio S.","family":"Dominelli","sequence":"additional","affiliation":[{"name":"Southern Medical Program University of British Columbia  Kelowna BC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik R.","family":"Swenson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary &amp; Critical Care Medicine VA Puget Sound Health Care System University of Washington  Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4110-9574","authenticated-orcid":false,"given":"Glen E.","family":"Foster","sequence":"additional","affiliation":[{"name":"Centre for Heart, Lung, and Vascular Health School of Health and Exercise Science University of British Columbia  Kelowna BC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,10,26]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"1086","article-title":"Acetazolamide use in severe chronic obstructive pulmonary disease. Pros and cons","volume":"14","author":"Adamson R.","year":"2017","journal-title":"Annals of the American Thoracic Society"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000313"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00509.2018"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1990.69.4.1397"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0317"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1978.03910060516009"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00256.2018"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2011.223925"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0019"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)92385-6"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2012.08.023"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1975.38.6.1095"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201306-201OC"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2011.1084"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2012.1099"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00134.2009"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.2.9911075"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01572.2005"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e6779"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199907000-00004"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.wem.2018.09.002"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0034-5687(94)00108-C"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.2165\/00007256-199723030-00002"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2017.03.002"},{"key":"e_1_2_8_26_1","first-page":"407","article-title":"Influence of central and peripheral PCO2 (pH) on the ventilatory response to hypoxic chemoceptor stimulation","volume":"12","author":"Riedstra J. W.","year":"1963","journal-title":"Acta Physiologica et Pharmacologica Neerlandica"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1977.43.6.1019"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1993.74.1.230"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200608-1199OC"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2006.110528"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2005.104174"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.5.9903088"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2004.01.001"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00012.2009"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00255.2009"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.2170\/jjphysiol.36.511"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00425.2014"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00787.2015"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c140040"},{"key":"e_1_2_8_40_1","first-page":"619","article-title":"Methazolamide and acetazolamide in acute mountain sickness","volume":"54","author":"Wright A. D.","year":"1983","journal-title":"Aviation Space and Environmental Medicine"}],"container-title":["Experimental Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1113\/EP088058","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1113\/EP088058","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/physoc.onlinelibrary.wiley.com\/doi\/pdf\/10.1113\/EP088058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T22:49:20Z","timestamp":1694126960000},"score":1,"resource":{"primary":{"URL":"https:\/\/physoc.onlinelibrary.wiley.com\/doi\/10.1113\/EP088058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,26]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1113\/EP088058"],"URL":"https:\/\/doi.org\/10.1113\/ep088058","archive":["Portico"],"relation":{},"ISSN":["0958-0670","1469-445X"],"issn-type":[{"value":"0958-0670","type":"print"},{"value":"1469-445X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,26]]},"assertion":[{"value":"2019-07-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}